Advertisement

Topics

AstraZeneca Teams Up with German Biotech to Develop mRNA Therapy

05:21 EDT 21 Aug 2017 | Labiotech.eu

AstraZeneca and its R&D arm MedImmune have partnered with Munich-based Ethris to use its mRNA technology to develop treatments for respiratory disease.  Ethris, located in the Munich biotech hub of Martinsried, has attracted the attention of AstraZeneca with its mRNA ...

This awesome article AstraZeneca Teams Up with German Biotech to Develop mRNA Therapy appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: AstraZeneca Teams Up with German Biotech to Develop mRNA Therapy

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca Teams Up with German Biotech to Develop mRNA Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...